Page last updated: 2024-11-05

beryllium chloride

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

beryllium chloride: RN given refers to BeCl2 [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

beryllium dichloride : A compound of beryllium (+2 oxidation state) and chloride in the ratio 1:2. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID24588
CHEBI ID62843
MeSH IDM0102005

Synonyms (21)

Synonym
becl2
einecs 232-116-4
nsc 84263
hsdb 357
ccris 4490
nsc-84263
beryllium chloride (becl2)
beryllium dichloride
beryllium chloride(becl2)
beryllium chloride
7787-47-5
wln: be g2
nsc84263
beryllium chloride, purified by sublimation, 99%
58b7024067 ,
unii-58b7024067
CHEBI:62843 ,
DTXSID10858756 ,
berylliumchlorid
beryllium;dichloride
dtxcid30809487

Research Excerpts

Overview

Beryllium chloride (BeCl(2) is a highly toxic substance that accumulates in different tissues after absorption.

ExcerptReferenceRelevance
"Beryllium chloride (BeCl(2)) is a highly toxic substance that accumulates in different tissues after absorption. "( Crocin "saffron" protects against beryllium chloride toxicity in rats through diminution of oxidative stress and enhancing gene expression of antioxidant enzymes.
Alghaithy, AA; Aly, HA; Doghish, AS; El-Beshbishy, HA; Hassan, MH, 2012
)
2.1
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (2)

RoleDescription
carcinogenic agentA role played by a chemical compound which is known to induce a process of carcinogenesis by corrupting normal cellular pathways, leading to the acquistion of tumoral capabilities.
genotoxinA role played by a chemical compound to induce direct or indirect DNA damage. Such damage can potentially lead to the formation of a malignant tumour, but DNA damage does not lead inevitably to the creation of cancerous cells.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (2)

ClassDescription
beryllium molecular entity
inorganic chloride
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (31)

TimeframeStudies, This Drug (%)All Drugs %
pre-199013 (41.94)18.7374
1990's6 (19.35)18.2507
2000's6 (19.35)29.6817
2010's6 (19.35)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 52.45

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be very strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index52.45 (24.57)
Research Supply Index3.47 (2.92)
Research Growth Index4.41 (4.65)
Search Engine Demand Index80.58 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (52.45)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies1 (3.23%)4.05%
Observational0 (0.00%)0.25%
Other30 (96.77%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]